Corcept Therapeutics Incorporated 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Directors: Joseph K. Belanoff, M.D.

Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: Joseph K. Belanoff, M.D.”): 76,965,512 for, 328,945 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 93 asset managers below reported 30,619,026 for, 20,494 withheld, 2 abstained, 66,551 not voted.

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

Description as filed by funds: Election of Directors: Gregg Alton

Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: Gregg Alton”): 67,977,943 for, 9,316,514 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 93 asset managers below reported 27,085,523 for, 3,553,933 withheld, 66 abstained, 66,551 not voted.

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

Description as filed by funds: Election of Directors: G. Leonard Baker, Jr.

Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: G. Leonard Baker, Jr.”): 64,912,506 for, 12,381,951 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 93 asset managers below reported 25,344,975 for, 5,294,463 withheld, 85 abstained, 66,551 not voted.

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

Description as filed by funds: Election of Directors: David L. Mahoney

Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: David L. Mahoney”): 51,078,278 for, 26,216,179 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 66% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 93 asset managers below reported 14,743,202 for, 15,896,146 withheld, 174 abstained, 66,551 not voted.

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

Description as filed by funds: Election of Directors: Joshua M. Murray

Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: Joshua M. Murray”): 76,753,606 for, 540,851 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 93 asset managers below reported 30,619,154 for, 20,364 withheld, 4 abstained, 66,551 not voted.

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

Description as filed by funds: Election of Directors: Kimberly Park

Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: Kimberly Park”): 70,288,833 for, 7,005,624 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 93 asset managers below reported 28,375,858 for, 2,269,611 withheld, 53 abstained, 66,551 not voted.

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

Description as filed by funds: Election of Directors: Daniel N. Swisher, Jr.

Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: Daniel N. Swisher, Jr.”): 67,594,098 for, 9,700,359 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 93 asset managers below reported 27,092,897 for, 3,552,559 withheld, 66 abstained, 66,551 not voted.

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

Description as filed by funds: Election of Directors: James N. Wilson

Corcept Therapeutics Incorporated’s own tally for this item (“Elect Director: James N. Wilson”): 72,730,017 for, 4,564,440 withheld, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2027 annual meeting of stockholders.”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 93 asset managers below reported 28,663,336 for, 1,982,153 withheld, 33 abstained, 66,551 not voted.

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

Description as filed by funds: To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan.

Corcept Therapeutics Incorporated’s own tally for this item (“4. Amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan”): 53,163,364 for, 23,867,363 against — passed, per its Form 8-K filed May 28, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 - The amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan was approved.”
Support: 69% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Corcept Therapeutics Incorporated’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 92 asset managers below reported 18,174,776 for, 12,291,035 against, 193,558 abstained, 90 not voted.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement.

Corcept Therapeutics Incorporated’s own tally for this item (“3. Compensation of named executive officers”): 72,511,429 for, 4,560,385 against — passed, per its Form 8-K filed May 28, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 - The compensation of named executive officers was approved, on an advisory basis.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 92 managers: 29,972,397 for, 674,700 against, 58,128 abstained, 66,551 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 290 managers: 23,564,908 for, 2,015,359 against, 8,075 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026.

Corcept Therapeutics Incorporated’s own tally for this item (“2. Appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 92,656,473 for, 569,010 against — passed, per its Form 8-K filed May 28, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 - The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 93 asset managers below reported 30,656,732 for, 28,426 against, 20,364 abstained, 66,551 not voted.

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.